NC
ONCE

NewSquare Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

NewSquare Capital’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-347
Closed -$28K – 342
2018
Q2 		$28K Hold
347
– – 0.01% 199
2018
Q1 		$23K Hold
347
– – 0.01% 201
2017
Q4 		$18K Hold
347
– – ﹤0.01% 206
2017
Q3 		$31K Buy
+347
New +$26.3K 0.01% 159

Other funds holding ONCE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

NewSquare Capital's ONCE Position: Q3 2018 in Review

NewSquare Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2018, closing a stake of 347 shares — an estimated $28K sold.

NewSquare Capital first reported a position in ONCE in Q3 2017 and held it in 4 quarters. The position peaked at $31K in Q3 2017. 176 funds tracked by Wall St. Rank hold ONCE as of Q3 2018.

  • NewSquare Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • NewSquare Capital sold 347 Spark Therapeutics, Inc. Common Stock shares in Q3 2018, an estimated $28K.
  • NewSquare Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
  • NewSquare Capital's Spark Therapeutics, Inc. Common Stock position peaked at $31K in Q3 2017.
  • 176 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2018.

Based on NewSquare Capital's 13F filing for Q3 2018, filed 19 Oct 2018.